Prospera Heart Transplant Assessment Test Validated, Launched
Natera, Inc. has announced the validation and availability of its Prospera Heart transplant assessment test for heart transplant recipients.
Read MorePosted by Chris Wolski | Aug 31, 2021 | Cardiovascular |
Natera, Inc. has announced the validation and availability of its Prospera Heart transplant assessment test for heart transplant recipients.
Read MorePosted by Chris Wolski | Aug 30, 2021 | Diabetes & Metabolic Diseases |
Testing for, monitoring, and controlling diabetes continues to become more robust, cost-effective, and nuanced.
Read MorePosted by Chris Wolski | Aug 23, 2021 | Cardiovascular |
Cardiovascular genetic testing in children presents unique challenges, requiring pre- and post-test counseling with an individualized approach for families.
Read MorePosted by Chris Wolski | Aug 23, 2021 | Lung Cancer |
Researchers have developed novel artificial intelligence blood testing technology that detected over 90% of lung cancers from 800 samples.
Read MorePosted by Chris Wolski | Aug 18, 2021 | Cancer |
A TrialJectory survey found that 90% of cancer patients understand the importance of genetic testing, but less than half have undergone NGS.
Read More